Item 2. Properties
1K characters. Original on sec.gov · Markdown
Item 2. Properties
Our global headquarters is located in Wilmington, Delaware, where we conduct global clinical development and commercial operations. We own three buildings comprising approximately 544,000 square feet of laboratory and office space at this site.
We lease approximately 112,000 square feet of office space in Chadds Ford, Pennsylvania.
We also conduct clinical development and commercial operations from our European headquarters in Morges, Switzerland and our Japanese office in Tokyo. Our large molecule production facility is located in Yverdon, Switzerland. Our Canadian office is in Montreal.
Previous: Item 1C. Cybersecurity · Next: Item 3. Legal Proceedings
Sponsor Sponsor this sector. One slot per industry, shown on every filing in it. Details